| 000 | 01655 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515073426.0 | ||
| 264 | 0 | _c20071211 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1398-2273 | ||
| 024 | 7 |
_a10.1111/j.1399-3062.2007.00203.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTong, S Y C | |
| 245 | 0 | 0 |
_aBreakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. _h[electronic resource] |
| 260 |
_bTransplant infectious disease : an official journal of the Transplantation Society _cSep 2007 |
||
| 300 |
_a241-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGraft vs Host Disease _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycetoma _xdrug therapy |
| 650 | 0 | 4 |
_aNaphthalenes _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 |
_aScedosporium _xisolation & purification |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 650 | 0 | 4 | _aTerbinafine |
| 650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aPeleg, A Y | |
| 700 | 1 | _aYoong, J | |
| 700 | 1 | _aHandke, R | |
| 700 | 1 | _aSzer, J | |
| 700 | 1 | _aSlavin, M | |
| 773 | 0 |
_tTransplant infectious disease : an official journal of the Transplantation Society _gvol. 9 _gno. 3 _gp. 241-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1399-3062.2007.00203.x _zAvailable from publisher's website |
| 999 |
_c17142031 _d17142031 |
||